NCT05662657 is a clinical trial of Diagnostic Test: PCL-S Questionnaire in Type 1 Diabetes, sponsored by Hospital St. Joseph, Marseille, France.

Who is sponsoring NCT05662657?

NCT05662657 is sponsored by Hospital St. Joseph, Marseille, France.

What drugs are being tested in NCT05662657?

Interventions in NCT05662657: Diagnostic Test: PCL-S Questionnaire.

What condition does NCT05662657 study?

NCT05662657 studies Type 1 Diabetes.

Is NCT05662657 still recruiting?

NCT05662657 is currently completed. Last updated 9 January 2026.

Last reviewed 2026-01-09 · How we verify

NCT05662657

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevalence of Post Traumatic Stress Disorder Related to Diabetes Diagnosis or Severe Hypoglycaemia in Adult With Type 1 Diabetes

Completed Last updated 9 January 2026

What this trial tests

trial testing Diagnostic Test: PCL-S Questionnaire in Type 1 Diabetes in 297 participants. Completed in 29 February 2024.

Timeline

30 November 2022

Primary endpoint
29 February 2024

29 February 2024

Quick facts

Lead sponsor	Hospital St. Joseph, Marseille, France
Status	Completed
Study type	OBSERVATIONAL
Enrollment	297
Start date	30 November 2022
Primary completion	29 February 2024
Estimated completion	29 February 2024
Sites	2 locations across France

Drugs / interventions tested

Diagnostic Test: PCL-S Questionnaire

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →

Sponsor

Hospital St. Joseph, Marseille, France

Who can join

18 and older, any sex, with Type 1 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In France, the adult population living with diabetes in 2016 is estimated at more than 3.3 million patients treated. Type 1 diabetes (T1DM) represents 5.6% of diabetic patients (approximately 185,000 patients). Numerous studies show that patients fear hypoglycemia, with an impact on their quality of life, sleep disorders and depressive symptoms. In addition, there is a metabolic impact with a problem of therapeutic compliance and an alteration of glycemic control. This study examine the relation between Post Traumatic Stress disorder (PTSD) and diabetes diagnosis or severe hypoglycaemia in adults with Type 1 Diabetes. The aim of this study is to evaluate the prevalence of PTSD in this population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other Hospital St. Joseph, Marseille, France trials

Trials by the same sponsor.

NCT05779735 — Validation of Ultrasound "Angle of Progression" Measurement to Decrease the Cesarean Rate · NA · unknown
NCT05068973 — Evaluation of the NOVATECH ® LUCIOLA TM EB Fiducial Marker During Radiotherapy Sessions in Lung Cancer Patients · NA · unknown
NCT04945746 — Dispersion Stability · NA · active not recruiting
NCT04672642 — Evaluation of the SpyGlass DS for Detection of Residual Pancreatic Calculations · NA · completed
NCT04839627 — Impact of Serum Progesterone Levels on the Day of Fresh and Frozen Embryo Transfer on the Ongoing Pregnancy Rates. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05662657 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital St. Joseph, Marseille, France
Last refreshed: 9 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05662657.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing